Passionate about
quality, research, and
innovation

Our expertise,
your quality
of life

Remarkable
and
unceasing
expansion

Elevating healthcare
through
international
partnerships

Through our relentless dedication, we have emerged as frontrunners in the fields of oncology, hematology, transplant cases, and rare diseases. Since 2004, we have proudly partnered with over 15 international companies and extended our reach to several other Latin American nations.

Our Commitment to
Excellence

Our primary focus is on developing and manufacturing high-quality pharmaceuticals, driven by an unwavering commitment to optimizing patient care. Our distinguished reputation stems from long-standing collaborations with the medical and scientific communities, where we prioritize innovation and continuous improvement in line with rigorous international quality standards.

Global and Latin American Products

+

360

registered
products worldwide

+

330

products in
Latin America

1

News

EC CL PE UY ARG
10.2024

ESMO 2024: Oncology advances with Varifarma!

A record-breaking congress with the latest innovations.  

ARG
09.2024

BOCIPAL® (Relugolix 40mg) HAS BEEN LAUNCHED!

A different approach to managing symptoms associated with uterine fibroids.

ARG
09.2024

Gorax Symposium: A Full House! Discover the Highlights

Connecting with the medical community at the 61st Argentine Congress of Urology, hosted by the SAU.

UY
08.2024

Varifarma presented new launch, VARITRINOX (Arsenic Trioxide)

As part of the Interior Conferences organized by the Hematology Society.

ARG
08.2024

Innovation arrives in Mycosis Fungoide treatment with Ledaga® (Chlomethine gel)

We launched Ledaga®, the first gel for the Treatment of Mycosis Fungoides Cutaneous T-Cell Lymphoma approved in Argentina.

ARG
08.2024

Gorax® (Relugolix 120mg) is now featured in NCCN and AAOC guidelines!

Both the medical community and Varifarma have reason to celebrate! Our product has been added to two of the leading medical recommendation guidelines.

UY
07.2024

¡Our new Uruguay website is live!

We're excited to unveil our new Uruguay website.

PE
07.2024

Varifarma in the XXIX Peruvian Congress of Neurology

Another year of expanding our scientific expertise in this academic event.

UY CL EC PE ARG
06.2024

Another year participating in the American Society of Clinical Oncology (ASCO) annual meeting!

In Varifarma we continue to take part in scientific events to stay at the forefront of new healthcare innovations.

UY ARG PE
06.2024

Introducing Endopredict, the prognostic test for Breast Cancer!

Find the latest news of this innovative test as a genomic tool to evaluate tumour behavior over the years for an accurate choice of treatment.

UY PER
04.2024

myChoice CDx Plus, recognized with Level of Evidence 1A

Our genomic test myChoice CDx Plus has been recognized by the ESGO-ESMO-ESP 2024 consensus with a Level of Evidence 1A.

ARG
04.2024

Launch of GORAX® at the International Symposium of the SAU

Varifarma launched GORAX® (Relugolix) at the International Symposium “Advances in Urology 2024” organized by the Argentine Society of Urology.

UY
10.2024

Varifarma: shaping the future of Hematology in Uruguay

We had the pleasure of attending the Hematology Update Conference on October 1st.

Bocipal Gorax Bozatinix Binap Nibclus Nadrib Anfonax Ixafnib Lenvatib Rupovar Janvax Macyn